• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.甲状腺切除术后放射性碘残留摄取:并非如此彻底的癌症手术。
Ann Surg Oncol. 2014 Apr;21(4):1379-83. doi: 10.1245/s10434-013-3450-3. Epub 2013 Dec 31.
2
Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.应用放射性碘-131 扫描测量分化型甲状腺癌全甲状腺切除术后手术学科、实践和数量对残留甲状腺组织的影响。
Head Neck. 2018 Oct;40(10):2129-2136. doi: 10.1002/hed.25204. Epub 2018 May 13.
3
Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.甲状腺微小乳头状癌患者的生活质量:甲状腺全切除术联合或不联合放射性碘消融治疗。
Endocrinol Metab (Seoul). 2020 Mar;35(1):115-121. doi: 10.3803/EnM.2020.35.1.115.
4
Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.1996年在德国接受治疗的原发性甲状腺分化癌患者的护理模式。美国和德国甲状腺癌研究小组。
Cancer. 2000 Jul 1;89(1):192-201. doi: 10.1002/1097-0142(20000701)89:1<192::aid-cncr26>3.0.co;2-7.
5
Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.具有乳头状核特征的大型非侵袭性滤泡性甲状腺肿瘤的转归
Thyroid. 2017 Apr;27(4):512-517. doi: 10.1089/thy.2016.0649. Epub 2017 Feb 24.
6
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.放射性碘用于重组人促甲状腺激素制剂后甲状腺残留消融,也具有重要的辅助治疗作用。
Thyroid. 2010 Mar;20(3):257-63. doi: 10.1089/thy.2009.0401.
7
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
8
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.
9
Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.全甲状腺切除及放射性碘残留消融术后中国分化型甲状腺癌患者预后的动态风险评估
Thyroid. 2017 Apr;27(4):531-536. doi: 10.1089/thy.2016.0479. Epub 2017 Jan 23.
10
Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.小儿分化型甲状腺癌的管理:儿科肿瘤医生的概述。
Pediatr Blood Cancer. 2020 Jun;67(6):e28141. doi: 10.1002/pbc.28141. Epub 2020 Apr 10.

引用本文的文献

1
Relation between surgical oncologic quality indicators for papillary thyroid cancer.甲状腺乳头状癌外科肿瘤学质量指标的相关性。
Can J Surg. 2022 Oct 4;65(5):E650-E655. doi: 10.1503/cjs.009121. Print 2022 Sep-Oct.
2
Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review.不同放射性碘剂量用于甲状腺残留组织消融后治疗的评估:一项系统综述
Iran J Pharm Res. 2022 May 14;21(1):e123825. doi: 10.5812/ijpr-123825. eCollection 2022 Dec.
3
Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis.通过 BRAF V600E 基因突变分析提高触诊引导下甲状腺结节细针抽吸细胞学检查的诊断灵敏度。
J Pathol Clin Res. 2021 Nov;7(6):556-564. doi: 10.1002/cjp2.231. Epub 2021 Jun 22.
4
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?放射性碘在分化型甲状腺癌中的应用:我们是否需要诊断性消融前碘-123闪烁扫描来优化治疗?
Diagnostics (Basel). 2021 Mar 19;11(3):553. doi: 10.3390/diagnostics11030553.
5
Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis-European Society of Endocrine Surgeons (ESES) positional statement.甲状腺手术的手术量、治疗效果及质量标准:循证分析——欧洲内分泌外科学会(ESES)立场声明
Langenbecks Arch Surg. 2020 Jun;405(4):401-425. doi: 10.1007/s00423-020-01907-x. Epub 2020 Jun 10.
6
Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer.分化型甲状腺癌放射性碘治疗剂量确定的相关因素
Nucl Med Mol Imaging. 2018 Aug;52(4):247-253. doi: 10.1007/s13139-018-0522-0. Epub 2018 May 2.
7
GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.评估不明甲状腺结节甲状腺切除术的范围:肿瘤学视角。
Endocr Pract. 2017 Apr 2;23(4):442-450. doi: 10.4158/EP161540.OR. Epub 2017 Jan 17.
8
Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study.预防格雷夫斯病患者术后低钙血症:一项前瞻性研究。
Ann Surg Oncol. 2015 Mar;22(3):952-8. doi: 10.1245/s10434-014-4077-8. Epub 2014 Sep 12.

本文引用的文献

1
Remnant uptake as a postoperative oncologic quality indicator.残瘤摄取作为术后肿瘤学质量指标。
Thyroid. 2013 Oct;23(10):1269-76. doi: 10.1089/thy.2012.0451. Epub 2013 Jul 17.
2
Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.在甲状腺细针穿刺细胞学报告的 Bethesda 系统中,不典型或意义不明确的滤泡性病变患者中,重复细针抽吸活检的产量和恶性肿瘤的发生率。
Surgery. 2012 Dec;152(6):1037-44. doi: 10.1016/j.surg.2012.08.052. Epub 2012 Oct 3.
3
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.术前诊断不确定细胞学的良性甲状腺结节。
N Engl J Med. 2012 Aug 23;367(8):705-15. doi: 10.1056/NEJMoa1203208. Epub 2012 Jun 25.
4
Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.全甲状腺切除术:分化型甲状腺癌患者手术时机对临床并发症和肿瘤学结局的影响。
World J Surg. 2012 May;36(5):1168-1173. doi: 10.1007/s00268-012-1484-5.
5
Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study.经验对甲状腺手术中个体外科医生表现的影响:前瞻性横断面多中心研究。
BMJ. 2012 Jan 10;344:d8041. doi: 10.1136/bmj.d8041.
6
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.基因突变检测对甲状腺细针穿刺细胞学检查结果不明确的甲状腺结节患者的诊断和治疗的影响:对 1056 例 FNA 样本的前瞻性分析。
J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7. doi: 10.1210/jc.2011-1469. Epub 2011 Aug 31.
7
Lobectomy versus total thyroidectomy in children with post-Chernobyl thyroid cancer: a 15 year follow-up.切尔诺贝利核事故后儿童甲状腺癌行 lobectomy 与 total thyroidectomy 的对比:15 年随访结果
Endocrine. 2011 Dec;40(3):432-6. doi: 10.1007/s12020-011-9500-3. Epub 2011 Jun 23.
8
Volume-based trends in thyroid surgery.甲状腺手术中基于容量的趋势。
Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1191-8. doi: 10.1001/archoto.2010.212.
9
Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy.体细胞突变的分子检测提高了甲状腺细针穿刺活检的准确性。
World J Surg. 2010 Nov;34(11):2589-94. doi: 10.1007/s00268-010-0720-0.
10
Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer.新诊断和复发性/残留甲状腺癌的手术治疗争议。
Thyroid. 2009 Dec;19(12):1373-80. doi: 10.1089/thy.2009.1606.

甲状腺切除术后放射性碘残留摄取:并非如此彻底的癌症手术。

Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.

作者信息

Oltmann Sarah C, Schneider David F, Leverson Glen, Sivashanmugam Tamilselvan, Chen Herbert, Sippel Rebecca S

机构信息

Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, Madison, WI, USA.

出版信息

Ann Surg Oncol. 2014 Apr;21(4):1379-83. doi: 10.1245/s10434-013-3450-3. Epub 2013 Dec 31.

DOI:10.1245/s10434-013-3450-3
PMID:24378987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3947670/
Abstract

BACKGROUND

Given limitations in preoperative diagnostics, thyroid lobectomy followed by completion thyroidectomy (CT) for differentiated thyroid cancer (DTC) may be required. It is unclear whether resection quality by CT differs from that by total thyroidectomy (TT). Additional surgeon or patient factors may also influence the "completeness" of resection. This study evaluated how CT and surgeon volume influence the adequacy of resection as measured by radioactive iodine (RAI) remnant uptake.

METHODS

A retrospective review of a prospectively collected thyroid database was queried for patients treated for DTC with TT or CT followed by RAI ablation. CT patients were matched 1:2 by age, sex, and tumor size to TT patients. Surgeon volume, time to completion, and continuity of surgeon care were reviewed.

RESULTS

Over 18 years, 45 patients with DTC had CT and RAI. Mean age was 48 ± 2 years, and 76 % were female, with a tumor size of 2.7 ± 0.3 cm. CT had higher remnant uptake than TT (0.07 vs. 0.04 %; p = 0.04). CT performed by a high-volume surgeon had much lower remnant uptakes (0.06 vs. 0.22 %; p = 0.04). Remnant uptake followed a stepwise decrease with involvement of a high-volume surgeon for part or all of the surgical management (p = 0.11). Multiple regression analysis found CT (p = 0.02) and surgeon volume (p = 0.04) to significantly influence uptake after controlling for other factors.

CONCLUSIONS

Single-stage TT provides a better resection based on smaller thyroid remnant uptakes than CT for patients with thyroid cancer. If a staged operation for cancer is necessary, surgeon volume may affect the completeness of resection.

摘要

背景

鉴于术前诊断存在局限性,分化型甲状腺癌(DTC)患者可能需要先进行甲状腺叶切除术,随后再行甲状腺全切术(CT)。目前尚不清楚CT的切除质量与甲状腺全切术(TT)相比是否存在差异。其他外科医生或患者因素也可能影响切除的“完整性”。本研究评估了CT和外科医生手术量如何通过放射性碘(RAI)残留摄取来影响切除的充分性。

方法

对前瞻性收集的甲状腺数据库进行回顾性查询,纳入接受TT或CT治疗后行RAI消融的DTC患者。根据年龄、性别和肿瘤大小,将CT患者与TT患者按1:2进行匹配。回顾外科医生手术量、完成时间以及外科医生护理的连续性。

结果

在18年期间,45例DTC患者接受了CT和RAI治疗。平均年龄为48±2岁,76%为女性,肿瘤大小为2.7±0.3cm。CT的残留摄取高于TT(0.07%对0.04%;p=0.04)。由高手术量外科医生进行的CT残留摄取要低得多(0.06%对0.22%;p=0.04)。随着高手术量外科医生参与部分或全部手术管理,残留摄取呈逐步下降趋势(p=0.11)。多因素回归分析发现,在控制其他因素后,CT(p=0.02)和外科医生手术量(p=0.04)对摄取有显著影响。

结论

对于甲状腺癌患者,基于较小的甲状腺残留摄取,单阶段TT比CT能提供更好的切除效果。如果癌症需要分期手术,外科医生手术量可能会影响切除的完整性。